ORGANOBALANCE Announces Substantial Investment
Berlin (Germany), 17 June 2010 – ORGANOBALANCE GmbH Berlin and Bernd Wegener DVM, PhD (Chairman of the Board of the German Federal Association of the Pharmaceutical Industry), have announced the completion of an investment agreement which shall take immediate effect. Aside from detailing a financial commitment, the agreement also foresees an active role for Dr Wegener in a position of responsibility at ORGANOBALANCE.
Dr Wegener's investment (the extent of which, as agreed between the parties, shall not be disclosed), his extensive experience, expertise and numerous contacts within the pharmaceutical and biotech industries, shall substantially promote and shape the continued successful development of ORGANOBALANCE GmbH.
Dr Wegener also envisages excellent prospects for their collaboration, commenting that "With innovative, patentable microorganisms and their active principles, we will be able to develop new diagnostic and therapeutic concepts and procedures particularly for hitherto inadequately treatable indications. I am very much looking forward to working with Professor Lang and ORGANOBALANCE, a leading company in this field, and opening up this as yet untapped potential".
All product and company names mentioned herein are possibly protected, and the property of ORGANOBALANCE GmbH or other companies.
For further information please contact:
Mrs Kristin Ebert
Tel.: +49 30 46307-200
Fax: +49 30 46307-210
ORGANOBALANCE GmbH is a company specialising in strain development and microbiological screening. ORGANOBALANCE taps the potential of beneficial microorganisms, known as specific probiotic cultures, in order to counteract, in a natural way, imbalances in the microflora, thus restoring the microbial equilibrium. In close cooperation with renowned industry partners, ORGANOBALANCE develops new biological products in the fields of pharmaceutics, preventive health care, nutrition and cosmetics. In its development activities the company draws on its own collection of microorganisms suitable for use in foodstuffs as well as its own OASSYS® screening systems. ORGANOBALANCE was founded in 2001 and is based in Berlin (Germany). More information can be found at www.organobalance.com.
About Dr Wegener
Bernd Wegener, DVM, has extensive managerial experience from diverse areas of responsibility in the pharmaceutical industry and relevant associations. After holding positions at Boehringer Ingelheim KG, Degussa Pharmagruppe, Marion Merrell Dow GmbH and Henning Berlin GmbH, he was Founder and Chairman of the Board of the B•R•A•H•M•S Group from 1994 to May 2010.
Dr Wegener is also Chairman of the Board of the German Federal Association of the Pharmaceutical Industry (BPI) as well as being a member of the board of various associations and supervisory boards.
Kommunikation . Marketing . Organisation
Tel.: +49 33 22 84 06 52
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ORGANOBALANCE Announces Substantial Investment here
News-ID: 135525 • Views: 1641
More Releases from ORGANOBALANCE GmbH
Increasing the Potential for Yeast Strains in Biotech Manufacturing
ORGANOBALANCE to present its latest research findings at ACHEMA 2012 Berlin, 13 June 2012 – At this year's ACHEMA (Frankfurt,18 to 22 June), the Berlin-based biotech company ORGANOBALANCE GmbH will present its most recent findings on the potential uses of yeast strains in the biotechnological production of fine chemicals and new ingredients for pharmaceuticals, cosmetics, foods or feedstuffs (metabolic engineering of yeasts). In his talk, The yeast Saccharomyces cerevisiae as platform organism
ORGANOBALANCE Signs Licensing Agreement with Sanofi Pasteur
Modified strain of yeast paves way for new industrial vaccine production process Berlin, 11 January 2012 – The company ORGANOBALANCE GmbH, Berlin, Germany, today announced the conclusion of a licensing agreement with Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY). This will provide Sanofi Pasteur with access to a modified yeast strain (Saccharomyces cerevisiae, more commonly known as baker's yeast) for use in vaccines. By signing the
Lonza and ORGANOBALANCE Enter Global License Agreement to Develop and Market Uni …
Basel, Switzerland and Berlin, Germany, 19 April 2011 – Lonza and ORGANOBALANCE today announced the signing of a worldwide exclusive license agreement in which Lonza will develop, produce and commercialize products containing a probiotic Lactobacillus strain. Developed by ORGANOBALANCE GmbH, the probiotic strain acts against Helicobacter pylori (H. pylori). Research shows that H. pylori has been implicated as a common cause of peptic ulcers and gastritis. Currently, about 50 percent of
ORGANOBALANCE to present latest research findings at the BIOTECHNICA Trade Show …
Berlin-based company to intensify efforts in contract research and white biotechnology Berlin, September 28, 2010 – Once again this year, ORGANOBALANCE will present current projects and latest research findings to an international audience of experts at the BIOTECHNICA Trade Show taking place in Hannover, Germany from October 5 to 7, 2010. Since 2001, the Berlin-based company has been doing research - primarily for clients from the fields of red, white and green
More Releases for Wegener
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 20 …
ReportsWorldwide has announced the addition of a new report title Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2017, provides an overview of the Granulomatosis with Polyangiitis (Wegener Polyangiitis) (Immunology) pipeline landscape. Wegener Polyangiitis is an uncommon disorder that causes inflammation of
Global Acetoacetanilide Market 2017- MUNSCH Plastic Welding Technology, Wegener …
ReportsMonitor.com has added Global Acetoacetanilide Market Professional Survey Report 2017. This report studies Acetoacetanilide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in Global Acetoacetanilide markets covering Eastman Chemical, Mitsuboshi Chemical, Laxmi Organic Industries, Cangzhou Goldlion Chemicals, Nantong Acetic Acid Chemical, Jiangsu
Global Hand Extruders Market 2017 By Key Manufacturers: VIRAX, Wegener Internati …
The motive of this strategic research report entitled “Global Hand Extruders Market 2017” is to provide company officials, industry investors and industry members with consequential insights to enable them make reliable strategic decisions regarding the opportunities in the global Hand Extruders market. Key Notes On Hand Extruders Market: “Global Hand Extruders Market 2017” offers crucial insights into the global Hand Extruders market along with the market size and estimates for the duration
Press Brakes Market 2017 - Euromac, Gasparini Industries, Prada Nargesa, Safan D …
Apex Research, recently published a detailed market research study focused on the "Press Brakes Market" across the global, regional and country level. The report provides 360° analysis of "Press Brakes Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Press Brakes industry, and estimates the future trend of Press Brakes market
Global Hand Extruders Market 2017 - MUNSCH Plastic Welding Technology, Leister T …
Worldwide Hand Extruders 2017 Research Report presents a professional and complete analysis of Global Hand Extruders Market on the current situation. In the first part, the report provides a general overview of the Hand Extruders industry 2017 including definitions, classifications, Hand Extruders market analysis, a wide range of applications and Hand Extruders industry chain structure. The 2017's report on Hand Extruders industry offers the global Hand Extruders development history, development trends
Information from Dennso AG: Wegener+Stapel Fördertechnik GmbH pursuing further …
Hamburg / Bergen, 24.08.2016. Wegener + Stapel, a premium supplier of conveying and picking systems, has recorded a significant increase in orders in the first half of 2016 and achieved strong growth in sales. Manfred W. Schleicher took over the company with a long tradition only in October 2015 together with the private equity investor Dennso AG and his partners by way of a Management Buy In (MBI). Now, Wegener